278 related articles for article (PubMed ID: 11869627)
1. Pressurised metered-dose inhalers versus all other hand-held inhalers devices to deliver bronchodilators for chronic obstructive pulmonary disease.
Ram FS; Brocklebank DM; Muers M; Wright J; Jones PW
Cochrane Database Syst Rev; 2002; 2002(1):CD002170. PubMed ID: 11869627
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
[TBL] [Abstract][Full Text] [Related]
3. Pressurised metered dose inhalers versus all other hand-held inhaler devices to deliver beta-2 agonist bronchodilators for non-acute asthma.
Ram FS; Brocklebank DM; White J; Wright JP; Jones PW
Cochrane Database Syst Rev; 2002; 2002(1):CD002158. PubMed ID: 11869625
[TBL] [Abstract][Full Text] [Related]
4. Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering beta (2 )agonists bronchodilators in asthma.
Ram FS; Wright J; Brocklebank D; White JE
BMJ; 2001 Oct; 323(7318):901-5. PubMed ID: 11668134
[TBL] [Abstract][Full Text] [Related]
5. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
[TBL] [Abstract][Full Text] [Related]
6. Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD.
van Geffen WH; Douma WR; Slebos DJ; Kerstjens HA
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011826. PubMed ID: 27569680
[TBL] [Abstract][Full Text] [Related]
7. Clinical effectiveness of the Respimat inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices.
Ram FS; Carvallho CR; White J
Int J Chron Obstruct Pulmon Dis; 2011; 6():129-39. PubMed ID: 21468167
[TBL] [Abstract][Full Text] [Related]
8. Tiotropium versus placebo for chronic obstructive pulmonary disease.
Karner C; Chong J; Poole P
Cochrane Database Syst Rev; 2012 Jul; (7):CD009285. PubMed ID: 22786525
[TBL] [Abstract][Full Text] [Related]
9. Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma.
Brocklebank D; Wright J; Cates C
BMJ; 2001 Oct; 323(7318):896-900. PubMed ID: 11668133
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of inhaler devices containing beta(2)-agonist bronchodilators in the treatment of asthma: cochrane systematic review and meta-analysis of more than 100 randomized, controlled trials.
Ram FS
Am J Respir Med; 2003; 2(4):349-65. PubMed ID: 14720001
[TBL] [Abstract][Full Text] [Related]
11. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
[TBL] [Abstract][Full Text] [Related]
12. [Chinese expert consensus on standardized inhaler device application in stable chronic airway diseases (2023)].
Inhalation Therapy and Respiratory Rehabilitation Group, Respiratory Equipment Committee of China Association of Medical Equipment
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1055-1067. PubMed ID: 37914418
[TBL] [Abstract][Full Text] [Related]
13. A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat Soft Mist Inhaler in patients with asthma and chronic obstructive pulmonary disease.
Kässner F; Hodder R; Bateman ED
Drugs; 2004; 64(15):1671-82. PubMed ID: 15257628
[TBL] [Abstract][Full Text] [Related]
14. Higher lung deposition with Respimat Soft Mist inhaler than HFA-MDI in COPD patients with poor technique.
Brand P; Hederer B; Austen G; Dewberry H; Meyer T
Int J Chron Obstruct Pulmon Dis; 2008; 3(4):763-70. PubMed ID: 19281091
[TBL] [Abstract][Full Text] [Related]
15. In vitro validation of a Respimat® adapter for delivery of inhaled bronchodilators during mechanical ventilation.
Dellweg D; Wachtel H; Höhn E; Pieper MP; Barchfeld T; Köhler D; Glaab T
J Aerosol Med Pulm Drug Deliv; 2011 Dec; 24(6):285-92. PubMed ID: 21870959
[TBL] [Abstract][Full Text] [Related]
16. Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease.
McCrory DC; Brown CD
Cochrane Database Syst Rev; 2001; 2001(2):CD002984. PubMed ID: 11406052
[TBL] [Abstract][Full Text] [Related]
17. Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease.
Nannini LJ; Cates CJ; Lasserson TJ; Poole P
Cochrane Database Syst Rev; 2007 Oct; (4):CD006829. PubMed ID: 17943918
[TBL] [Abstract][Full Text] [Related]
18. New developments in inhaler devices within pharmaceutical companies: A systematic review of the impact on clinical outcomes and patient preferences.
Ninane V; Vandevoorde J; Cataldo D; Derom E; Liistro G; Munghen E; Peché R; Schlesser M; Verleden G; Vincken W
Respir Med; 2015 Nov; 109(11):1430-8. PubMed ID: 26439177
[TBL] [Abstract][Full Text] [Related]
19. Use of Respimat Soft Mist inhaler in COPD patients.
Anderson P
Int J Chron Obstruct Pulmon Dis; 2006; 1(3):251-9. PubMed ID: 18046862
[TBL] [Abstract][Full Text] [Related]
20. A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD.
Voshaar T; Lapidus R; Maleki-Yazdi R; Timmer W; Rubin E; Lowe L; Bateman E
Respir Med; 2008 Jan; 102(1):32-41. PubMed ID: 17996436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
